Skip to main content
. Author manuscript; available in PMC: 2017 Jun 6.
Published in final edited form as: Mol Pharm. 2016 May 24;13(6):1904–1914. doi: 10.1021/acs.molpharmaceut.6b00069

Figure 7.

Figure 7

Exposure levels of HA in the heart, spleen, liver, kidney, bladder, and trachea based on molecular weight with 7 and 29 kDa HA on top, 67 and 215 kDa HA in the middle, and 741 kDa HA on the bottom as a percentage of delivered dose over time for each of the five HA molecular weights. Each point is an average of at least five animals with the error on each point <5% of the measurement.